当前蛋白身份:P49427 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
2OB4 Human Ubiquitin-Conjugating Enzyme CDC34 提交 2006-12-18 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 7–184(178 aa) 片段:Catalytic Domain: Residues 7-184
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.5;298 K;The protein was dissolved at 42 mg/ml in 20 mM Tris-HCl, pH 8.0, 0.15 M NaCl, 5% glycerol and 2 mM DTT. Crystals were grown in hanging drops by mixing 2 microL protein solution with 2 microL well solution (28% PEG 4000, 0.1 M Tris-HCl, pH 8.5, 0.2 M MgCl2, 1 mM DTT and 7.5 mM glycyl-glycyl-glycine) at 21 deg C. For cryoprotection, the crystals were soaked in the well solution supplemented with 25% ethylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 2.40 Å R-free 0.284
3RZ3 Human Cdc34 E2 in complex with CC0651 inhibitor 提交 2011-05-11 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 7–184(178 aa) 片段:unp residues 7-184
未记录 U94 4,5-dideoxy-5-(3',5'-dichlorobiphenyl-4-yl)-4-[(methoxyacetyl)amino]-L-arabinonic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;0.5M NaH2PO4, 1.6M K2HPO4, 0.1 M Imidazole, 0.2 M NaCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.30 Å R-free 0.258
3RZ3 Human Cdc34 E2 in complex with CC0651 inhibitor 提交 2011-05-11 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 7–184(178 aa) 片段:unp residues 7-184
未记录 U94 4,5-dideoxy-5-(3',5'-dichlorobiphenyl-4-yl)-4-[(methoxyacetyl)amino]-L-arabinonic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;0.5M NaH2PO4, 1.6M K2HPO4, 0.1 M Imidazole, 0.2 M NaCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.30 Å R-free 0.258
3RZ3 Human Cdc34 E2 in complex with CC0651 inhibitor 提交 2011-05-11 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 7–184(178 aa) 片段:unp residues 7-184
未记录 U94 4,5-dideoxy-5-(3',5'-dichlorobiphenyl-4-yl)-4-[(methoxyacetyl)amino]-L-arabinonic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;0.5M NaH2PO4, 1.6M K2HPO4, 0.1 M Imidazole, 0.2 M NaCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.30 Å R-free 0.258
3RZ3 Human Cdc34 E2 in complex with CC0651 inhibitor 提交 2011-05-11 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 7–184(178 aa) 片段:unp residues 7-184
未记录 U94 4,5-dideoxy-5-(3',5'-dichlorobiphenyl-4-yl)-4-[(methoxyacetyl)amino]-L-arabinonic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;0.5M NaH2PO4, 1.6M K2HPO4, 0.1 M Imidazole, 0.2 M NaCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.30 Å R-free 0.258
4MDK Cdc34-ubiquitin-CC0651 complex 提交 2013-08-22 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 7–184(178 aa) 片段:E2 domain (UNP residues 7-184)
未记录 U94 4,5-dideoxy-5-(3',5'-dichlorobiphenyl-4-yl)-4-[(methoxyacetyl)amino]-L-arabinonic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;28% PEG3350, 0.1 M HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.61 Å R-free 0.259
4MDK Cdc34-ubiquitin-CC0651 complex 提交 2013-08-22 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 7–184(178 aa) 片段:E2 domain (UNP residues 7-184)
未记录 U94 4,5-dideoxy-5-(3',5'-dichlorobiphenyl-4-yl)-4-[(methoxyacetyl)amino]-L-arabinonic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;28% PEG3350, 0.1 M HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.61 Å R-free 0.259
4MDK Cdc34-ubiquitin-CC0651 complex 提交 2013-08-22 Assembly 3 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 7–184(178 aa) 片段:E2 domain (UNP residues 7-184)
未记录 U94 4,5-dideoxy-5-(3',5'-dichlorobiphenyl-4-yl)-4-[(methoxyacetyl)amino]-L-arabinonic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;28% PEG3350, 0.1 M HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.61 Å R-free 0.259
4MDK Cdc34-ubiquitin-CC0651 complex 提交 2013-08-22 Assembly 4 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 D 7–184(178 aa) 片段:E2 domain (UNP residues 7-184)
未记录 U94 4,5-dideoxy-5-(3',5'-dichlorobiphenyl-4-yl)-4-[(methoxyacetyl)amino]-L-arabinonic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;28% PEG3350, 0.1 M HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.61 Å R-free 0.259
7M2K CDC34A-Ubiquitin-2ab inhibitor complex 提交 2021-03-16 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 7–184(178 aa)
未记录 GZM 4-[(3',5'-dichloro[1,1'-biphenyl]-4-yl)methyl]-N-ethyl-1-(methoxyacetyl)piperidine-4-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;0.1M HEPES pH 7.0 29% PEG3350 40 mM DL-Malic acid 5 mM DTT
分辨率 2.47 Å R-free 0.276
7M2K CDC34A-Ubiquitin-2ab inhibitor complex 提交 2021-03-16 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 7–184(178 aa)
未记录 GZM 4-[(3',5'-dichloro[1,1'-biphenyl]-4-yl)methyl]-N-ethyl-1-(methoxyacetyl)piperidine-4-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;0.1M HEPES pH 7.0 29% PEG3350 40 mM DL-Malic acid 5 mM DTT
分辨率 2.47 Å R-free 0.276
7M2K CDC34A-Ubiquitin-2ab inhibitor complex 提交 2021-03-16 Assembly 3 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 E 7–184(178 aa)
未记录 GZM 4-[(3',5'-dichloro[1,1'-biphenyl]-4-yl)methyl]-N-ethyl-1-(methoxyacetyl)piperidine-4-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;0.1M HEPES pH 7.0 29% PEG3350 40 mM DL-Malic acid 5 mM DTT
分辨率 2.47 Å R-free 0.276
7M2K CDC34A-Ubiquitin-2ab inhibitor complex 提交 2021-03-16 Assembly 4 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 G 7–184(178 aa)
未记录 GZM 4-[(3',5'-dichloro[1,1'-biphenyl]-4-yl)methyl]-N-ethyl-1-(methoxyacetyl)piperidine-4-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;0.1M HEPES pH 7.0 29% PEG3350 40 mM DL-Malic acid 5 mM DTT
分辨率 2.47 Å R-free 0.276
8RX0 (NEDD8)-CRL2VHL-MZ1-Brd4BD2-Ub(G76S, K48C)-UBE2R1(C93K, S138C, C191S, C223S)-Ub 提交 2024-02-05 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 9 PDB 声明:nonameric(9) 与蛋白数一致
链 G 1–236(236 aa)
未记录 759 (2~{S},4~{R})-1-[(2~{S})-2-[2-[2-[2-[2-[2-[(9~{S})-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaen-9-yl]ethanoylamino]ethoxy]ethoxy]ethoxy]ethanoylamino]-3,3-dimethyl-butanoyl]-~{N}-[[4-(4-methyl-2,3-dihydro-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide × 1 ZN ZINC ION × 3 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.70 Å